| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of COL5A1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:70920 | 6480464 | Ethinyl Estradiol results in increased expression of COL5A1 mRNA | CTD | PMID:12655037 PMID:12075121 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:733435 | 6480464 | Ethinyl Estradiol results in increased expression of COL5A1 mRNA | CTD | PMID:18936297 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of COL5A1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL5A1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:70920 | 6480464 | Ethinyl Estradiol affects the expression of COL5A1 mRNA | CTD | PMID:16079270 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:70920 | 6480464 | Ethinyl Estradiol results in increased expression of COL5A1 mRNA | CTD | PMID:12075121 PMID:12655037 |
| 17beta-estradiol | decreases expression | ISO | RGD:733435 | 6480464 | Estradiol results in decreased expression of COL5A1 mRNA | CTD | PMID:19167446 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of COL5A1 mRNA | CTD | PMID:20702594 PMID:16962184 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of COL5A1 mRNA | CTD | PMID:16962184 PMID:20702594 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of COL5A1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL5A1 mRNA | CTD | PMID:17942748 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL5A1 mRNA] | CTD | PMID:18200517 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of COL5A1 mRNA | CTD | PMID:18200517 |
| 2-methylcholine | affects expression | ISO | RGD:733435 | 6480464 | beta-methylcholine affects the expression of COL5A1 mRNA | CTD | PMID:21179406 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of COL5A1 mRNA | CTD | PMID:20713471 |
| 4-phenylbutyric acid | increases expression | ISO | RGD:733435 | 6480464 | 4-phenylbutyric acid results in increased expression of COL5A1 mRNA | CTD | PMID:14583596 |
| 7,12-dimethyltetraphene | decreases expression | ISO | RGD:70920 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL5A1 mRNA | CTD | PMID:12376462 |
| alachlor | increases expression | ISO | RGD:70920 | 6480464 | alachlor results in increased expression of COL5A1 mRNA | CTD | PMID:12419858 |
| alendronic acid | affects expression | ISO | RGD:70920 | 6480464 | Alendronate affects the expression of COL5A1 mRNA | CTD | PMID:16079270 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of COL5A1 mRNA | CTD | PMID:16604517 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:733435 | 6480464 | Tretinoin results in decreased expression of COL5A1 mRNA | CTD | PMID:21934132 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to COL5A1 promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of COL5A1 mRNA | CTD | PMID:15034205 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of COL5A1 mRNA | CTD | PMID:21569818 |
| bisphenol A | increases expression | ISO | RGD:70920 | 6480464 | bisphenol A results in increased expression of COL5A1 mRNA | CTD | PMID:12075121 |
| C60 fullerene | increases expression | ISO | RGD:70920 | 6480464 | fullerene C60 results in increased expression of COL5A1 mRNA | CTD | PMID:19167457 |
| chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of COL5A1 mRNA | CTD | PMID:23125180 |
| chloroprene | decreases expression | ISO | RGD:70920 | 6480464 | Chloroprene results in decreased expression of COL5A1 mRNA | CTD | PMID:23125180 |
| ciglitazone | decreases expression | ISO | RGD:70920 | 6480464 | ciglitazone results in decreased expression of COL5A1 mRNA | CTD | PMID:22193206 |
| crocidolite asbestos | decreases expression | ISO | RGD:733435 | 6480464 | Asbestos, Crocidolite results in decreased expression of COL5A1 mRNA | CTD | PMID:18687144 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL5A1 mRNA] | CTD | PMID:18200517 |
| cyclosporin A | increases expression | ISO | RGD:733435 | 6480464 | Cyclosporine results in increased expression of COL5A1 mRNA | CTD | PMID:20106945 |
| cytarabine | decreases expression | ISO | RGD:733435 | 6480464 | Cytarabine results in decreased expression of COL5A1 mRNA | CTD | PMID:21198554 |
| dexamethasone | decreases expression | ISO | RGD:70920 | 6480464 | Dexamethasone results in decreased expression of COL5A1 mRNA | CTD | PMID:14618091 PMID:20032058 |
| dexamethasone | decreases expression | ISO | RGD:70920 | 6480464 | Dexamethasone results in decreased expression of COL5A1 mRNA | CTD | PMID:20032058 PMID:14618091 |
| dexamethasone | multiple interactions | ISO | RGD:70920 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL5A1 mRNA] | CTD | PMID:20032058 |
| diazoxide | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of COL5A1 mRNA | CTD | PMID:21335049 |
| dimethyl sulfoxide | increases expression | ISO | RGD:70920 | 6480464 | Dimethyl Sulfoxide results in increased expression of COL5A1 mRNA | CTD | PMID:22193206 |
| diuron | increases expression | ISO | RGD:70920 | 6480464 | Diuron results in increased expression of COL5A1 mRNA | CTD | PMID:21551480 |
| genistein | increases expression | ISO | RGD:70920 | 6480464 | Genistein results in increased expression of COL5A1 mRNA | CTD | PMID:12075121 |
| isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of COL5A1 mRNA | CTD | PMID:21335049 |
| isotretinoin | increases expression | ISO | RGD:733435 | 6480464 | Isotretinoin results in increased expression of COL5A1 mRNA | CTD | PMID:20436886 |
| naphthalene | increases expression | EXP | | 6480464 | naphthalene results in increased expression of COL5A1 mRNA | CTD | PMID:18978301 |
| nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of COL5A1 mRNA | CTD | PMID:16166746 |
| ozone | affects expression | ISO | RGD:70920 | 6480464 | Ozone affects the expression of COL5A1 mRNA | CTD | PMID:16716893 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:70920 | 6480464 | perfluorooctanoic acid results in decreased expression of COL5A1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of COL5A1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of COL5A1 mRNA | CTD | PMID:17426115 |
| raloxifene | affects expression | ISO | RGD:70920 | 6480464 | Raloxifene affects the expression of COL5A1 mRNA | CTD | PMID:16079270 |
| resveratrol | decreases expression | ISO | RGD:733435 | 6480464 | resveratrol results in decreased expression of COL5A1 mRNA | CTD | PMID:19167446 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of COL5A1 mRNA | CTD | PMID:16274305 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of COL5A1 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:733435 | 6480464 | tert-Butylhydroperoxide results in decreased expression of COL5A1 mRNA | CTD | PMID:15336504 |
| testosterone | multiple interactions | ISO | RGD:70920 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL5A1 mRNA] | CTD | PMID:20032058 |
| testosterone enanthate | affects expression | ISO | RGD:733435 | 6480464 | testosterone enanthate affects the expression of COL5A1 mRNA | CTD | PMID:17440010 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of COL5A1 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases expression | ISO | RGD:70920 | 6480464 | Carbon Tetrachloride results in increased expression of COL5A1 mRNA | CTD | PMID:17056239 |
| tetradecane | decreases expression | ISO | RGD:70920 | 6480464 | n-tetradecane results in decreased expression of COL5A1 protein | CTD | PMID:17337753 |
| trans-resveratrol | decreases expression | ISO | RGD:733435 | 6480464 | resveratrol results in decreased expression of COL5A1 mRNA | CTD | PMID:19167446 |
| vanadium atom | decreases expression | ISO | RGD:733435 | 6480464 | Vanadium results in decreased expression of COL5A1 mRNA | CTD | PMID:19000753 |
| vanadium(0) | decreases expression | ISO | RGD:733435 | 6480464 | Vanadium results in decreased expression of COL5A1 mRNA | CTD | PMID:19000753 |